System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

CHRS

$1.63-3.55%

Coherus Biosciences Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

20Overripe

Live Analysis Active

Company Mission

Coherus Biosciences Inc creates biosimilar drugs, which are cheaper versions of expensive brand-name medications. Hospitals and pharmacies buy these drugs to save money on treatments for patients. The company makes money by selling these drugs, helping reduce healthcare costs.

CHR

Industry Context

Coherus operates in the biotechnology sector, focusing on biosimilars that compete with high-cost brand drugs. This industry benefits from increasing demand for affordable healthcare solutions. Companies like Coherus face competition from larger pharmaceutical firms but can gain market share through cost-effective products.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

67Matrix

Market Momentum

42.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-3.55%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CHRS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 11:09 PM UTC

As-of As of 2026-03-15T22:54:30.097Z UTC (~15m delay).

Develops and sells biosimilar drugs that mimic expensive brand-name medications, generating revenue through sales to healthcare providers and insurers.

Price is compressing on the weekly chart near $2, suggesting potential volatility expansion soon. Watch for a breakout above this level.

Weekly pattern shows price compressing near $2, indicating potential volatility expansion as buyers and sellers balance. Monitor if it holds above this support.

Weekly chart compression around $2 signals potential volatility, with a breakout likely. Watch for price movement above this key level.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...